应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
WHWK Whitehawk Therapeutics, Inc.
盘后交易 01-13 18:09:11 EST
2.75
+0.18
+7.00%
盘后
2.75
+0.00
0.00%
16:10 EST
最高
2.78
最低
2.46
成交量
18.52万
今开
2.60
昨收
2.57
日振幅
12.45%
总市值
1.30亿
流通市值
5,987万
总股本
4,713万
成交额
48.94万
换手率
0.85%
流通股本
2,177万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Whitehawk Therapeutics, Inc.盘中异动 股价大跌5.30%
市场透视 · 01-13 01:31
Whitehawk Therapeutics, Inc.盘中异动 股价大跌5.30%
Whitehawk Therapeutics, Inc.盘中异动 快速下挫5.90%报2.55美元
市场透视 · 01-10
Whitehawk Therapeutics, Inc.盘中异动 快速下挫5.90%报2.55美元
WhiteHawk Therapeutics凭借Hwk-007的IND许可进入临床阶段,并宣布提交Hwk-016的IND申请
美股速递 · 01-08
WhiteHawk Therapeutics凭借Hwk-007的IND许可进入临床阶段,并宣布提交Hwk-016的IND申请
Whitehawk Therapeutics, Inc.盘中异动 大幅上涨5.28%报2.79美元
市场透视 · 2025-12-24
Whitehawk Therapeutics, Inc.盘中异动 大幅上涨5.28%报2.79美元
加载更多
公司概况
公司名称:
Whitehawk Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Whitehawk Therapeutics, Inc.于2007年11月16日在特拉华州成立。该公司是一家临床阶段的生物制药公司,为基因定义的癌症开发精准疗法。该公司的主要目标是为mTOR通路驱动因子变化的癌症患者带来转化疗法,例如TSC1或TSC2基因的变化,而mTOR抑制剂由于药理学、有效药物递送、安全性或有效性问题而没有或不能得到有效利用。Aadi的主要产品是FYARROTM,这是一种mTOR抑制剂,可与人类蛋白质结合,并显示出更高的肿瘤积累、更大的mTOR靶点抑制和增强的肿瘤生长抑制。
发行价格:
--
{"stockData":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":2.75,"timestamp":1768338000000,"preClose":2.57,"halted":0,"volume":185224,"hourTrading":{"tag":"盘后","latestPrice":2.75,"preClose":2.75,"latestTime":"16:10 EST","volume":303,"amount":833.25,"timestamp":1768338603934},"delay":0,"floatShares":21770230,"shares":47128362,"eps":-0.309934,"marketStatus":"盘后交易","change":0.18,"latestTime":"01-13 18:09:11 EST","open":2.6,"high":2.78,"low":2.46,"amount":489390.462153,"amplitude":0.124514,"askPrice":2.75,"askSize":12,"bidPrice":2.5,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.309934,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768352400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.57,"postHourTrading":{"tag":"盘后","latestPrice":2.75,"preClose":2.75,"latestTime":"16:10 EST","volume":303,"amount":833.25,"timestamp":1768338603934},"volumeRatio":1.926022,"impliedVol":1.5594,"impliedVolPercentile":0.5169},"requestUrl":"/m/hq/s/WHWK","defaultTab":"news","newsList":[{"id":"2603521809","title":"Whitehawk Therapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603521809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603521809?lang=zh_cn&edition=full","pubTime":"2026-01-13 01:31","pubTimestamp":1768239115,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日01时31分,Whitehawk Therapeutics, Inc.股票出现异动,股价快速跳水5.30%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.67%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Cellectar Biosciences, Inc.、Beam Therapeutics Inc.涨幅较大,Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃,换手率分别为642.52%、132.36%、100.72%,振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Mindwalk Holdings Corp.,振幅分别为32.48%、31.29%、31.25%。Whitehawk Therapeutics, Inc.公司简介:Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113013155a7127730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113013155a7127730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","WHWK","LENZ","BK4539"],"gpt_icon":0},{"id":"2602830959","title":"Whitehawk Therapeutics, Inc.盘中异动 快速下挫5.90%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602830959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602830959?lang=zh_cn&edition=full","pubTime":"2026-01-10 02:21","pubTimestamp":1767982871,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日02时21分,Whitehawk Therapeutics, Inc.股票出现波动,股价大幅跳水5.90%。截至发稿,该股报2.55美元/股,成交量4.4599万股,换手率0.09%,振幅4.43%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。其相关个股中,Novabay Pharmaceuticals, Inc.、Cg Oncology, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃,换手率分别为640.51%、78.12%、47.91%,振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Akoustis Technologies Inc、Revolution Medicines Inc C/Wts 17/12/2026 ,振幅分别为53.49%、38.11%、35.11%。Whitehawk Therapeutics, Inc.公司简介:Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011002211197a157d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011002211197a157d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WHWK","BK4139","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"1182864798","title":"WhiteHawk Therapeutics凭借Hwk-007的IND许可进入临床阶段,并宣布提交Hwk-016的IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1182864798","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182864798?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:07","pubTimestamp":1767877644,"startTime":"0","endTime":"0","summary":"生物制药公司WhiteHawk Therapeutics迎来重要里程碑,其候选药物Hwk-007已获得新药临床试验(IND)许可,标志着公司正式迈入临床开发阶段。与此同时,WhiteHawk Therapeutics还宣布已提交另一款候选药物Hwk-016的IND申请,进一步拓展其研发管线。\n这一进展凸显了公司在创新疗法开发上的持续动力,也为后续的临床研究奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"gpt_icon":0},{"id":"2594282908","title":"Whitehawk Therapeutics, Inc.盘中异动 大幅上涨5.28%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594282908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594282908?lang=zh_cn&edition=full","pubTime":"2025-12-24 23:20","pubTimestamp":1766589646,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日23时20分,Whitehawk Therapeutics, Inc.股票出现异动,股价快速上涨5.28%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,奥麦罗制药、Indaptus Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大,Dermata Therapeutics, Inc.、Indaptus Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为1766.77%、1194.23%、59.51%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Citius Pharmaceuticals, Inc.、Indaptus Therapeutics, Inc.,振幅分别为62.58%、52.88%、32.82%。Whitehawk Therapeutics, Inc.公司简介:Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224232047953b9d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224232047953b9d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","WHWK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.whitehawktx.com","stockEarnings":[{"period":"1week","weight":0.0158},{"period":"1month","weight":0.1078},{"period":"3month","weight":0.3046},{"period":"6month","weight":0.3179},{"period":"1year","weight":-0.2861},{"period":"ytd","weight":0.062}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Whitehawk Therapeutics, Inc.于2007年11月16日在特拉华州成立。该公司是一家临床阶段的生物制药公司,为基因定义的癌症开发精准疗法。该公司的主要目标是为mTOR通路驱动因子变化的癌症患者带来转化疗法,例如TSC1或TSC2基因的变化,而mTOR抑制剂由于药理学、有效药物递送、安全性或有效性问题而没有或不能得到有效利用。Aadi的主要产品是FYARROTM,这是一种mTOR抑制剂,可与人类蛋白质结合,并显示出更高的肿瘤积累、更大的mTOR靶点抑制和增强的肿瘤生长抑制。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.164798},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.0383},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.227585},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.018337},{"month":5,"riseRate":0.857143,"avgChangeRate":0.190811},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.069397},{"month":7,"riseRate":0.375,"avgChangeRate":-0.025419},{"month":8,"riseRate":0.625,"avgChangeRate":0.031865},{"month":9,"riseRate":0.625,"avgChangeRate":0.003135},{"month":10,"riseRate":0.125,"avgChangeRate":-0.092738},{"month":11,"riseRate":0.625,"avgChangeRate":0.077853},{"month":12,"riseRate":0.5,"avgChangeRate":-0.084464}],"exchange":"NASDAQ","name":"Whitehawk Therapeutics, Inc.","nameEN":"Whitehawk Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Whitehawk Therapeutics, Inc.(WHWK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Whitehawk Therapeutics, Inc.,WHWK,Whitehawk Therapeutics, Inc.股票,Whitehawk Therapeutics, Inc.股票老虎,Whitehawk Therapeutics, Inc.股票老虎国际,Whitehawk Therapeutics, Inc.行情,Whitehawk Therapeutics, Inc.股票行情,Whitehawk Therapeutics, Inc.股价,Whitehawk Therapeutics, Inc.股市,Whitehawk Therapeutics, Inc.股票价格,Whitehawk Therapeutics, Inc.股票交易,Whitehawk Therapeutics, Inc.股票购买,Whitehawk Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Whitehawk Therapeutics, Inc.(WHWK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}